Viewing Study NCT02281318


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-04-01 @ 9:22 PM
Study NCT ID: NCT02281318
Status: COMPLETED
Last Update Posted: 2018-08-06
First Post: 2014-10-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Sponsor: GlaxoSmithKline
Organization: